[London, 7 September 2022] – Shiraz Austin, Augnito Co-Founder and expert in AI-driven speech recognition addresses the current challenges and risks associated in radiology reporting.
Radiologists are facing increased pressure to manage NHS resource shortages. With unprecedented backlogs, delays in training newly qualified consultants and demand increasing with every passing day, Trusts and healthcare providers need new ways to reduce discrepancies in diagnostics and radiology reporting errors to ultimately drive the cost of risk down.
Shiraz Austin, Co-Founder of Augnito, stated: “There is a financial cost and a very real human cost to risk and errors in radiology. Issues with radiology reporting – often due to workloads, reporting accuracy, or radiologist cognitive overload expose Trusts to litigation, expose radiologists to burnout and withdrawal from the profession at a time when they are most needed, and expose patients to inferior care/health standards, or worst still, life limiting outcomes.”
According to NHS statistics ¹, 12,629 clinical claims were made against the NHS in 2020/21 at a cost of around £2 billion. Perhaps more alarming is that this number of claims was 133% higher than nine years ago demonstrating a significant increase year on year.
Austin continued: “These numbers are unacceptable, the human cost is unacceptable. While radiologists are addressing diagnostic risks by taking proactive steps to reduce errors at every stage, ensuring reporting accuracy, backlogs, and checking accuracy standards in the solutions they use, remain vital components of their service, there are digital solutions that can help support them and radiology as a whole. Solutions using speech recognition (SR) technology can ease the workload backlog and mitigate risks.”
“Advances in today’s SR solutions help to streamline workflow, improve transparency and promote clinician efficiency. Augnito’s voice-AI-driven technology is highly accurate straight out of the box and works with radiologists however and wherever they need to work. It assists radiologists to report faster without errors, whilst embracing reporting standards through consistently structured formats and a natural learning processing engine with natural language understanding.
The cost of errors and delays to the NHS – through litigation, or in time lost as each day passes without accurate solutions being implemented – and in patient care, placing a risk to life, cannot continue in the current upward trend. In its first year of launching, Augnito’s technology is already deployed across a large percentage of the UK’s radiology reporting and teleradiology platforms ̶ accurately supporting radiologists every day in their key patient-care role. Our mission to democratize speech recognition across the whole continuum of care has only just started” concluded Austin.
ENDS
Read the full blog here https://www.scribetech.co.uk/2022/08/30/the-costs-of-risk-and-errors-in-radiology-reporting/
For further information, interview opportunities or accompanying graphics please contact: Georgina Pavelin, Mixed Media – [email protected]
About Augnito
Augnito is a secure, cloud-based, AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialties, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible everywhere. Augnito was developed by its parent company Scribetech, a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text and clinical coding solutions for the healthcare sector, and its own speech recognition engine with advanced voice AI technology.
www.scribetech.co.uk/augnito-speechrecognition
¹ https://resolution.nhs.uk/resources/annual-report-statistics/
[London, 30 August 2022] – Augnito cloud-based speech recognition technology highlights why data security is a concern for radiologists and NHS Trusts.
While the healthcare sector and the NHS face increased pressure to adopt new technology, Scribetech (UK) Ltd, developers of Augnito, a clinical AI-powered speech recognition solution, reports widespread concerns over security and patient data.
According to Scribetech, security is a key barrier to adopting speech recognition – despite its potential to accelerate reporting time, drive accuracy, and enable radiologists to deal with a significant backlog.
Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder for Augnito, stated: “The security question is one we encounter a lot. The way radiologists work needs to evolve, but Trusts have understandable concerns about any new technology and how it handles sensitive patient data. That’s why security and compliance has been key to Augnito’s development from the very start.”
The most common concerns from Trusts around new technology cross three key areas:
1. The transfer of data to the cloud – specifically how data is protected against unauthorised access in storage and
transit
2. How data is used to improve AI – and how information is anonymized and encrypted before it is fed into any machine
learning algorithm
3. Consistency in compliance – including where data is transferred during processing, particularly where this may
include multiple regulatory jurisdictions
Austin continued: “It’s not enough for cloud technology providers to simply say they are secure. We’ve taken proactive steps to embed security at every level of Augnito, so it’s a solution that Trusts – and radiologists – can really feel confident about using.”
Augnito is a next-generation speech recognition solution, available on desktops, mobile devices and web browsers, or integrated with existing clinical systems. This diverse range of application/s is supported by industry leading security and compliance, including:
– Data security, quality control, and management processes certified under DSPT, Cyber Essentials+, UKAS ISO 9001,
ISO 14001, BSI – ISO 27001
– A speech recognition engine hosted by Amazon Web Services (AWS) in the UK
– Anonymised, encrypted data at rest, stored exclusively in the UK and compliant with GDPR
– Automated backup options in AWS to prevent data loss
As a result, radiologists can adopt speech recognition without compromising on the safety of data and, ultimately, patients. However, Austin also reports measurable improvements to data integrity, made possible by Augnito: “Augnito keeps data safe as standard. But it also brings new levels of accuracy and consistency to reports, through both our 99.3% accurate AI and templates. Compared to manually typed reports, which are prone to errors and mistakes, Augnito is actually driving higher report quality. All while lessening the burden on radiologists and helping key diagnostic decisions be made sooner.”
ENDS
Note to editors
About Scribetech and Augnito
Scribetech (UK) Ltd. is a clinical voice-AI solution and disruptive technology provider. Founded in 2001, the company has accumulated two decades of experience as an approved supplier of clinical transcription services to the NHS and private healthcare providers. This expertise has been combined with eight years of AI research and development partnerships established with engineers, analysts, and clinicians. The result is Augnito: an innovative, secure, cloud-based clinical speech recognition solution. Augnito brings seamless speech-enablement to daily workflows. All with 99.3% at-the-cursor accuracy, support for multiple medical specialities, and no need for voice profile training.
Visit www.scribetech.co.uk/2022/07/31/the-role-of-speech-recognition-in-radiology-security-risk-and-compliance/ for the full blog post relating to this media alert. Contact [email protected] for more product details.
For further press-media information, interview opportunities or accompanying graphics please contact: Georgina Pavelin, Mixed Media – [email protected]
[London, 24 August 2022] – Augnito’s latest blog addresses the current challenges within radiology and poses efficiency solutions to manage the backlogs with direct improvements on patient care.
Understaffing is a real challenge across the NHS, however within radiology this is nothing new, the pandemic only compounding an existing problem which continues to await solution. At this time, radiology continues to be severely understaffed, resulting in scan backlogs, while falling below safe staffing quotas making it impossible to keep up with demand. Those in post are at risk of burn out, with staff morale affected and many planning to cut their hours or leave the NHS. The Royal College of Radiologists’ estimates today’s consultant capacity at just a third of the required workforce. Without intervention, that shortfall is expected to hit 44% by 2025.1
Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito, stated: “We are at a critical point across the NHS with unprecedented staff shortages and resulting backlogs. Not only is this alarming for healthcare professionals working to mitigate the risks, but for patients, particularly within radiology where early diagnosis can quite literally save lives. Without appropriate staffing resources, patient care is delayed, therefore diagnosis takes longer, as does resulting treatment. Every day that passes without a solution only adds to the workload, scan backlogs and staff pressure.
Until there are more consultants in training and protection of existing staff on the front-line an immediate solution is required, a new way of working needs to be implemented to aid backlogs, give visual results and offer well needed support.”
Scribetech offers expert health-tech and speech recognition (SR) advice to mitigate risks; the latest blog tackles individual efficiency, support for radiologists to deliver exceptional care to patients and the long-term effect of efficient reporting using the company’s SR solution, Augnito.
Austin continued: “Technology is ever evolving and providing access to the latest AI voice driven clinical speech recognition solution will support the backlogs whilst mitigating the increase in reporting demand. The right technology helps staff do more in less time, more accurately, and more flexibly supporting today’s workstyle.”
Augnito AI-driven speech recognition accurately generates reports. Available in the cloud with no need for additional hardware or software, Augnito gives every radiologist a much faster and more flexible way of working – one that helps accurate diagnoses happen sooner.
Today, accurate speech recognition can lessen the burden on radiologists, improve workloads, and increase wellbeing and workforce retention. So perhaps the real question is ‘why the delay, what are you waiting for?’
ENDS
For further information, interview opportunities or accompanying graphics please contact: Georgina Pavelin, Mixed Media – [email protected]
About Scribetech
Scribetech (UK) Ltd is a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text and clinical coding solutions for the healthcare sector, and its own speech recognition engine and advanced voice AI technology.
About Augnito
Created by Scribetech, Augnito is its secure, cloud-based, AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialties, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible everywhere.
www.scribetech.co.uk/augnito-speechrecognition
https://www.scribetech.co.uk/2022/06/01/why-efficiency-is-key-to-raising-standards-in-radiology/
1 https://www.rcr.ac.uk/system/files/publication/field_publication_files/clinical-radiology-uk-workforce-census-2020-report.pdf
[London, 23 June 2022] – In 1962 the first speech recognition* (SR) technology could recognise just 16 words in English. Fast forward 60 years and SR is built into most elements of our daily lives. And yet in healthcare, SR solutions are not used to their full potential, until now – there is a new voice-driven AI product suite is offering a more accurate alternative.
UKIO is back as a face-to-face event with a refreshed 3-day congress, programme and exhibition that will showcase the latest state-of-the-art equipment, services, technology and content aimed at addressing issues in the fields of diagnostic imaging, oncology, and radiology. This year’s theme ‘Harnessing disruption: Clinical excellence in a time of chaos’ mirrors the innovation and technology behind Augnito – a next gen clinical speech recognition solution introduced to the UK healthcare market last Autumn.
Since its launch Augnito has already recorded positive sales and trading interest. Born from Scribetech’s 20 year partnership with the NHS to promote patient data accuracy and clinician efficiency benefits, the Augnito speech recognition product suite has secured over 150 installations in healthcare environments across England.
More recently the Augnito team have been sharing their success with industry partners in the radiology sector while celebrating a number of live pilots and positive implementations that have taken advantage of the speech-enabling benefits provided by the Augnito API & SDK solution.
Shiraz Austin, Co-Founder for Augnito comments, “Augnito was built from the ground up in collaboration with engineers, analysts, and clinicians to offer an alternative to the legacy speech recognition products currently available on the market. With extensive transcription experience, 8 years R&D, disruptive innovation technology and a true commitment to clinicians’ needs, we are proud to offer a highly accurate, secure, cloud-based, portable and cost effective alternative”.
Radiology departments have been the early adopters of speech recognition technology to accommodate the ever-increasing levels of diagnostic reporting and the -expanding modality spectrum. Augnito offers this sector an improved, more efficient way, to deliver their service using the streamlining benefits that come with voice-driven AI technology.
“Augnito partners are as critical for its continued market growth, just as Augnito is a key contributor to its partners’ success in speech enabling clinical systems and effectively accelerating digital transformation in the healthcare sector. Augnito offers partners a unique cloud-based technology, which they can easily integrate and rapidly deploy, not just to improve the productivity of busy customers and reduce the cost of clinical documentation, but to also gain healthy business resell margins.”
“Augnito’s aim is to democratize the use of clinical speech recognition software through a selective network of ISVs, VARs, and managed service providers that have a healthcare focus. Augnito also provides services, support and guidance, to partners’ customers either considering, implementing, or already ‘live’ on a medical information system.” concludes Austin.
Augnito can be seen in action, integrated into different clinical reporting platforms at UKIO in Liverpool, 4-6 July, on its attending partner stands; Hexarad A28, Wellbeing Software B45 Fujifilm B46 and Cimar UK B58.
ENDS
For further information, interview opportunities or accompanying graphics please contact: Georgina Pavelin – Mixed Media ([email protected])
About Scribetech and Augnito
Scribetech (UK) Ltd. is a clinical voice solutions and disruptive technology provider. Founded in 2001, the company has accumulated two decades of experience as an approved supplier of clinical transcription services to the NHS and private healthcare providers.
Now, this expertise has been combined with 8 years of AI research and development partnerships established with engineers, analysts, and clinicians. The result is Augnito: an innovative, secure, cloud-based clinical speech recognition solution. Augnito brings seamless speech-enablement to daily workflows. All with 99% at-the-cursor accuracy, support for multiple medical specialities and no need for voice profile training. www.scribetech.co.uk/augnito-speechrecognition
About UKIO
The United Kingdom Imaging & Oncology Congress (UKIO) is the permanent amalgamation of two well-known conferences – the UK Radiological Congress (UKRC) and the UK Radiation Oncology Conference (UKRO). 2019 was the first year that this unified event ran as UKIO. In 2020 and 2021, UKIO ran as an online event. In 2022, the Congress will return as an in-person event. This annual event consists of a three-day multidisciplinary scientific congress with a programme that showcases the most cutting-edge content for a multidisciplinary audience that addresses the medical, scientific, educational and management issues in the diverse fields of diagnostic imaging, oncology, and radiological sciences. Alongside this is a large professional exhibition of the latest state-of-the-art equipment, services and technology available in the industry. The event attracts around 2,000 attendees. The 2022 theme is Harnessing disruption: Clinical excellence in a time of chaos. https://www.ukio.org.uk/
References
*https://www.ibm.com/ibm/history/exhibits/specialprod1/specialprod1_7.html
[London, 21 June 2022] – With an open API and fast integration, Augnito’s AI-powered speech recognition engine makes Hexarad’s radiology reporting platform faster, easier to use and more accurate.
With widespread NHS staff shortages and increased pressure to provide fast, error-free imaging reporting, the technology that supports radiologists is constantly evolving. Now, Hexarad – one of the UK’s leading radiology platform providers – has adopted Augnito: an innovative, AI-based medical speech recognition solution.
With Augnito’s proven speech recognition in the cloud, Hexarad’s speech-enabled platform empowers radiologists with a faster, more flexible way of reporting.
Developed in partnership with clinicians, Augnito gives radiologists fast, easy ways to capture live clinical data on any device with 99.3% accuracy. This is made possible by a sophisticated, AI-driven engine that intelligently and accurately captures patient data in any accent, including medical and clinical terms. Available in the cloud, adopting Augnito is quick, easy and requires no on-premise hardware or in-house support and maintenance.
Crucially, Augnito understands the way radiologists need to work and the importance of speech recognition that’s deeply integrated with other clinical systems.
“Beyond our user-suite of applications, Augnito includes a comprehensive API and SDK, allowing clinical systems to easily become speech enabled,” says Shiraz Austin, Co-Founder and Managing Director at Scribetech (UK) Ltd. “It’s important to us that the time-saving benefits of speech recognition are accessible to as many healthcare professionals as possible, even in the familiar systems they’re already using. Our partnership with Hexarad is a great example of two best-in-class technologies working seamlessly together.”
The Augnito API allowed Hexarad to replace an existing speech recognition solution and embed accurate, real-time speech-to-text data entry into its radiology reporting platform, Optirad. The API also provides better support for integrating voice commands, saving radiologists time every day.
For Hexarad, Augnito offered the right blend of accurate technology and fast, flexible integration.
“Augnito did exactly what we needed it to do, seamlessly and efficiently,” says Dr Jaymin Patel, Chief Operating Officer for Hexarad. “The integration provided a rapid deployment and roll-out for us, taking a total of just 12 weeks. The API was outstanding and entirely customisable to our needs.”
Today, Hexarad is using Augnito to support all 60 of its radiologists, enabling them to spend more time on the detailed analysis of patients’ scans as well as increasing the number of scans and reports they complete, without compromising on accuracy. This creates a better way of working, decreases the pressure from growing workloads and, ultimately, helps patients get the diagnoses they need sooner.
ENDS
NOTES TO EDITORS
For further information, interview opportunities or accompanying graphics please contact: Georgina Pavelin, Mixed Media, [email protected]
About Scribetech and Augnito
Scribetech (UK) Ltd is a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text and clinical coding solutions for the healthcare sector, and its own speech recognition engine and advanced voice AI technology.
Augnito is Scribetech’s secure, cloud-based and AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99.3% accuracy, support for multiple medical specialties, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible, everywhere. www.scribetech.co.uk/augnito-speechrecognition
About Hexarad
Hexarad is a leading radiology platform based across the UK and Ireland. Its bespoke built-in workflow management software solution, Optirad, helps hospitals manage their own radiology resources better, improve productivity and efficiency allowing team leaders to deliver patient -centred service with timely and accurate scan reporting to streamline departments and existing resources. They also provide a full service teleradiology solution to ensure fast, accurate diagnosis for everyone, everywhere.
[London, 18 May 2022] – The developers of Augnito a secure, cloud-based and AI-driven clinical speech recognition product suite, have recorded dramatic Q1 growth in the UK following the launch of its new flagship solution.
Clinical speech recognition (SR) solutions developer, Scribetech, has recorded rapid sales growth for its recently launched secure and portable AI-driven clinical SR product suite Augnito, which offers fast, effortless ways to capture live clinical data, on any device, with 99.3% accuracy.
Augnito was launched in late 2021 with active sales taking off in Q1 2022, its first UK trading quarter. The company has already secured in excess of 150 implementations in healthcare environments across England and a number of live pilots with NHS Trusts are also underway. The uplift has been driven by demand for its solution in the radiology sector, which has soared as the health service deals with the backlogs in imaging and reporting created by the pandemic.
The developers of Augnito are now setting their sights higher, aiming for sustained sales growth in its next financial year and is determined to continue to disrupt the clinical SR healthcare market. To help drive that, the business has also launched a dedicated channel program looking to sign up value-added resellers and managed service providers that have a healthcare focus and the technical skills necessary to deliver IT solutions for the market.
Shiraz Austin, Co-Founder for Augnito & Managing Director at Scribetech (UK) Ltd, said: “From the outset, Augnito was built in close partnership with clinicians, using human-centred design, to create a Natural Language Processing engine to fit their needs – not the other way round. As a result, Augnito offers excellent support for a wide variety of clinical vocabulary and workflows and this is what has driven market interest in, and sales of, our voice-AI solution.”
Since the beginning of the year Augnito has also been signed up by a number of strategic technology partners where its API and SDK product is augmenting workflows with cutting-edge technology to transform healthcare institutions to improve patient care across all departments.
Partnerships already underway include a leading supplier of specialist clinical information solutions Wellbeing Software, Cimar, a cloud-native health information medical imaging platform, and Hexarad, a UK leading teleradiology service provider and one of the UK’s fastest growing start-ups.
“We are extremely pleased with our performance. It’s really a strong validation of our vision and product capabilities; customers are increasingly looking to solutions such as ours which address a number of core issues that confront those on the healthcare frontline, such as improving efficiency and accuracy, as well as optimising clinical workflows,” added Austin.
Augnito is a secure and portable AI-driven clinical SR product suite that offers fast, effortless ways to capture live clinical data, on any device, with 99.3% accuracy. The SaaS cloud-based solution is proven to create highly accurate clinical records, improving the timing on everything from patient diagnosis to patient hospital stays in delayed transfers of care. Radiology departments have been the earlier adopters and pioneers of speech recognition technology to accommodate the ever-increasing levels of a wide variety of diagnostic reporting and the ever-expanding modality spectrum. Augnito now offers this sector an improved, more efficient way, to deliver their service using the benefits that voice-driven AI technology has to offer.
Developed as a cloud-based technology by Scribetech and based on 20 years of hands-on-experience delivering transcription and digital dictation services to the NHS, Augnito removes the need for healthcare IT teams to support the solution with additional hardware and/or software. Product application enhancements are also delivered in the cloud as soon as they are ready for release, without the need to upgrade locally installed versions. This reduces dependency on IT resource teams, potential associated product downtime, delays, and costs.
Austin concluded: “The investment we have made year-to-date represents the biggest outside of our Indian market. Furthermore, we have made additional investments in growing our UK channel footprint, with new management expertise now in place specifically to develop those partner relationships.”
“As we enter our new financial year, we have our sights on further international expansion powered by the growth in sales and revenue. It is our intention to add to a global Augnito team with our eyes firmly on the USA, APAC and Midle Eastern markets in the immediate term building on our successes here in the UK and India.”